Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Stimulates new blood vessel growth to improve nutrient delivery to injured tissues through VEGFR2 pathway activation Enhances fibroblast activity and collagen synthesis for stronger tissue repair and improved structural integrity Increases GH receptor expression making tissues more responsive to natural repair signals Modulates inflammatory response to reduce pain and prevent excessive tissue damage from prolonged inflammation Cell migration represents another critical mechanism
What is the best next step
Longevity and cellular peptides work on the longest timeline months of consistent use, with benefits that often outlast the course itself
A cart and a disclaimer mean nobody did
Why Compounding Access Is Not an Established Path Positioning in the Metabolic Medicine Conversation For physicians fielding patient questions about 5-amino-1MQ, the appropriate framing: Promising mechanism with solid preclinical rationale Early clinical development human efficacy and safety not yet well characterized No legitimate clinical access pathway in the United States as of 2026 Alternative evidence-based options exist for the underlying metabolic optimization goals patients typically pursue Key Takeaways 5-amino-1MQ is a small-molecule NNMT inhibitor, not a peptide
